FIGURE 5
Exosomal miR‐92b‐3p and Apatinib represent the synergistic anti‐angiogenic effect. (A) Inhibition rates of tube formation and migration of HUVECs treated with Apatinib or miR‐92b‐3p mimics alone or both combined (mean ± SD,
FIGURE 5
Exosomal miR‐92b‐3p and Apatinib represent the synergistic anti‐angiogenic effect. (A) Inhibition rates of tube formation and migration of HUVECs treated with Apatinib or miR‐92b‐3p mimics alone or both combined (mean ± SD,